« Back to Record
Citation APA

Rossi, C., Gilhodes, J., Maerevoet, M., Herbaux, C., Morschhauser, F., Brice, P., Garciaz, S., Borel, C., Ysebaert, L., Obéric, L., Lazarovici, J., Deau, B., Dupuis, J., Chauchet, A., Abraham, J., Bijou, F., Stamatoullas-Bastard, A., Malfuson, J. V., Golfier, C., Laurent, C., Pericart, S., Traverse-Glehen, A., Kanoun, S., Filleron, T., Casasnovas, R. O., & Ghesquieres, H. (2018). Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers. American journal of hematology, 93(8), 1042-1049. doi:10.1002/ajh.25154


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/280435

Rossi, C., Gilhodes, J., Maerevoet, M., Herbaux, C., Morschhauser, F., Brice, P., Garciaz, S., Borel, C., Ysebaert, L., Obéric, L., Lazarovici, J., Deau, B., Dupuis, J., Chauchet, A., Abraham, J., Bijou, F., Stamatoullas-Bastard, A., Malfuson, J. V., Golfier, C., Laurent, C., Pericart, S., Traverse-Glehen, A., Kanoun, S., Filleron, T., Casasnovas, R. O., & Ghesquieres, H. (2018). Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers. American journal of hematology, 93(8), 1042-1049. doi:10.1002/ajh.25154